Dispensary of Hope Welcomes sanofi-aventis U.S.
as Latest Participant in the Continued Access
July 28, 2010 01:54 PM Eastern Daylight Time
NASHVILLE, Tenn.--(EON: Enhanced Online News)--The Dispensary of Hope is pleased to announce that
sanofi-aventis U.S., the U.S. affiliate of sanofi-aventis, a leading global pharmaceutical company, has become the
latest pharmaceutical company to participate in the Dispensary’s Continued Access Program, which provides
uninsured patients with access to medicines that they otherwise couldn’t afford.
As part of the Continued Access Program, sanofi-aventis U.S. will assist the Dispensary of Hope in providing access
to prescription medications. Sanofi-aventis U.S. provides medications in a variety of therapeutic areas including
cardiology, internal medicine, as well as diabetes which is one of the most common health issues facing the
Dispensary of Hope patients.
“It is important to our organization to use every avenue possible as we work to provide our patients with medications
that are needed for daily life, so to have sanofi-aventis U.S. join us as we strive to seek and dispense medications
speaks highly of the company’s commitment to help patients in need obtain quality prescription medication,” said
Scott Cornwell, chief operating officer of Dispensary for Hope.
“Sanofi-aventis U.S. has a long track record of helping patients in need. We are pleased to join with the Dispensary
of Hope’s Continued Access Program to help the growing patient population who cannot afford their prescription
medications,” said Anthony Piagentini, Senior Manager, Patient Assistance Programs for sanofi-aventis U.S.
Through innovative stewardship of the pharmaceutical supply-chain, the Dispensary of Hope has been able to
develop a national distribution center and pharmacy to support a network of dispensing sites and direct-to-patient
About the Dispensary of Hope
Founded in 2003, the Dispensary of Hope is a not-for-profit social venture t